Deal snapshot: Xbiome Acquires M201 Programme from Assembly Biosciences.

MANews-(C)2009-2022

Massachusetts, US-based microbiome therapeutics company Xbiome Inc. has acquired the clinical-stage M201 Programme of California-based biotechnology company Assembly Biosciences, Inc., to strengthen position in microbiome therapeutics, the company said.

Terms of the transaction were not disclosed. The M201 Programme...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT